SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-16-464698
Filing Date
2016-02-16
Accepted
2016-02-16 13:52:34
Documents
1
Group Members
BIOMARK CAPITAL FUND IV GP LLCDAVID S. WETHERELL

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d124881dsc13ga.htm SC 13G/A 66894
  Complete submission text file 0001193125-16-464698.txt   68581
Mailing Address 11588 SORRENTO VALLEY ROAD SUITE 20 SAN DIEGO CA 92121
Business Address 11588 SORRENTO VALLEY ROAD SUITE 20 SAN DIEGO CA 92121 8582599405
MABVAX THERAPEUTICS HOLDINGS, INC. (Subject) CIK: 0001109196 (see all company filings)

IRS No.: 930987903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-60385 | Film No.: 161426214
SIC: 2834 Pharmaceutical Preparations

Mailing Address 537 STEAMBOAT RD., SUITE 200 GREENWICH CT 06830
Business Address 537 STEAMBOAT RD., SUITE 200 GREENWICH CT 06830 203-769-2345
BIOMARK CAPITAL FUND IV LP (Filed by) CIK: 0001614166 (see all company filings)

IRS No.: 452626874 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A